Advertise on podcast: OnCall

In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the Inflation Reduction Act negotiations, thoughts from Congress going into November midterms, and future next steps for legislation. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about common challenges and best practices for bispecifics. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement bispecifics in a clinical practice. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement bispecifics in your practice. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they give an overview on the basics of bispecifics. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the 2026 legislative outlook, drug policy updates, market consolidation issues, and physician payment issues. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us a rundown on operationalizing radiopharmaceuticals in your practice. That is a wrap on our radiopharmaceutical series and we are excited for you to hear our upcoming episodes on legislation and bispecifics. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on billing and reimbursement of radiopharmaceuticals. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on the landscape surrounding radiopharmaceuticals. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an introduction to the basics of radiopharmaceuticals. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Joel White, Partner and Head of Health at Monument Advocacy, talks about updates on DC legislative and regulatory issues, what to expect in 2026 for physician and hospital payments and the Rural Health fund, drug reimbursement and what to expect when IRA prices go live January 1, 2026, and Obamacare subsidies and what happens if they expire. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on drug pricing/MFN. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines. For IRA specific questions, please reach out to [email protected]. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms. If you have questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers. If you have questions for our guests, or suggestions for future topics, email us at [email protected]. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.